Emerging Medications
May 2023
in “
Elsevier eBooks
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 58
- Therapeutic Implications of Topical Cetirizine 1% in Treatment of Male Androgenetic Alopecia: A Case-Controlled Study
- Combination Therapy with Topical Minoxidil and Nano-Microneedle-Assisted Fibroblast Growth Factor for Male Androgenetic Alopecia: A Randomized Controlled Trial in Chinese Patients
- Efficacy of a Cosmetic Phyto-Caffeine Shampoo in Female Androgenetic Alopecia
- Clascoterone as a Novel Treatment for Androgenetic Alopecia
- At The Crossroads Of Two Alopecias: Androgenetic Alopecia Pattern Of Hair Regrowth In Patients With Alopecia Areata Treated With Oral Janus Kinase Inhibitors
- The Effect of Intradermal Botulinum Toxin on Androgenetic Alopecia and Its Possible Mechanism
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Caffeine and Its Pharmacological Benefits in the Management of Androgenetic Alopecia: A Review
- Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
- A Small Dose of Botulinum Toxin A Is Effective for Treating Androgenetic Alopecia in Chinese Patients
- Intradermal Injections of a Hair Growth Factor Formulation for Enhancement of Human Hair Regrowth: Safety and Efficacy Evaluation in a First-in-Man Pilot Clinical Study
- Alopecia Areata: Treatment Options and Efficacy
- A Preliminary Study on Topical Cetirizine in the Therapeutic Management of Androgenetic Alopecia
- Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia
- An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% Versus Minoxidil 5% Solution in Male Androgenetic Alopecia
- A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males
- Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation
- Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients
- Topical Adenosine Increases the Proportion of Thick Hair in Caucasian Men With Androgenetic Alopecia
- Pharmacologic Inhibition of JAK-STAT Signaling Promotes Hair Growth
- Topical Adenosine Increases Thick Hair Ratio in Japanese Men with Androgenetic Alopecia
- Potential Targets in the Discovery of New Hair Growth Promoters for Androgenic Alopecia
- Differential Effects of Caffeine on Hair Shaft Elongation, Matrix and Outer Root Sheath Keratinocyte Proliferation, and Transforming Growth Factor-β2/Insulin-Like Growth Factor-1-Mediated Regulation of the Hair Cycle in Male and Female Human Hair Follicles In Vitro
- Comparing the Effectiveness of Local Solution of Minoxidil and Caffeine 2.5% with Local Solution of Minoxidil 2.5% in Treatment of Androgenetic Alopecia
- Comparison of the Efficacy of Topical Minoxidil 5% and Adenosine 0.75% Solutions on Male Androgenetic Alopecia and Measuring Patient Satisfaction Rate
- The Prostamide-Related Glaucoma Therapy, Bimatoprost, Offers a Novel Approach for Treating Scalp Alopecias
- Effects of Topical Application of Growth Factors Followed by Microneedle Therapy in Women with Female Pattern Hair Loss: A Pilot Study
- Prostaglandin D2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia
- Topical Melatonin for Treatment of Androgenetic Alopecia
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell Alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Hair Regrowth Following a Wnt- and Follistatin-Containing Treatment: Safety and Efficacy in a First-in-Man Phase 1 Clinical Trial
- A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia
- Novel Treatment of Female-Pattern Androgenetic Alopecia with Injected Bimatoprost 0.03% Solution
- Topical and Intralesional Therapies for Alopecia Areata
- Prospective Cohort Study on the Effects and Tolerability of Flutamide in Patients with Female Pattern Hair Loss
- Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- Adenosine Increases Anagen Hair Growth And Thick Hairs In Japanese Women With Female Pattern Hair Loss: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial
- Topical Fulvestrant Solution Has No Effect on Male and Postmenopausal Female Androgenetic Alopecia: Results from Two Randomized, Proof-of-Concept Studies
- Melatonin and the Hair Follicle
- Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women
- Adenosine Stimulates Fibroblast Growth Factor-7 Gene Expression Via Adenosine A2b Receptor Signaling in Dermal Papilla Cells
- Estrogen Receptor Antagonist and Hair Regrowth in Dogs with Hair Cycle Arrest (Alopecia X)
- Effect of Caffeine and Testosterone on the Proliferation of Human Hair Follicles In Vitro
- Influence of Prostaglandin F2α and Its Analogues on Hair Regrowth and Follicular Melanogenesis in a Murine Model
- Hypertrichosis of the Eyelashes Caused by Bimatoprost
- Acquired Trichomegaly of the Eyelashes and Hypertrichosis Induced by Bimatoprost
- Hypertrichosis of Vellus Hairs in the Malar Region After Unilateral Treatment with Bimatoprost
- Topical Estrogen Therapy for Androgenetic Alopecia in Menopausal Females
- Treatment of Hyperandrogenic Alopecia in Women
- Androgen-Inducible TGF-β1 from Balding Dermal Papilla Cells Inhibits Epithelial Cell Growth: A Clue to Understanding Paradoxical Effects of Androgen on Human Hair Growth
- Prostaglandin-Induced Hair Growth
- Fluridil, A Rationally Designed Topical Agent For Androgenetic Alopecia: First Clinical Experience
- Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial
- Molecular Mechanisms Regulating Hair Follicle Development
- Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil
- Treatment of Female Androgenetic Alopecia With Cimetidine